06 Nov ILT2 Blockade and MHC class I Regulation: Enhancing Immune Effector Functions in Glioblastoma.

Posted at 16:45h in INMUNOTHERAPY by

ID: 03337

Authors: Aguilar-García, Candelaria (1,2,3); Martínez-Pérez, Alejandra (1,2,3); Sordo-Bahamonde, Christian (1,2,3); Granda-Díaz, Rocío (1,2,3); Lorenzo-Herrero, Seila (1,2,3); Fernández-Vega, Iván (2,3,4,5); Hermida-Prado, Francisco (2,3,6,7); González, Segundo (1,2,3)

Topic: INMUNOTHERAPY